BioCentury
ARTICLE | Financial News

Epizyme proposes IPO

April 22, 2013 7:00 AM UTC

Epizyme Inc., Cambridge, Mass. Business: Cancer Date announced: 4/18/13 Type: IPO To be raised: Up to $69 million Shares: TBD Price: TBD Underwriters: Citigroup; Cowen; Leerink; JMP Securities; Wedbus...